GPCR / G Protein
-
BMS-927711
Catalog No. A13102 CGRP receptor 拮抗剂BMS-927711是一种有效的,选择性的,竞争性的人降钙素基因相关肽(CGRP)受体拮抗剂,已显示出体内功效,而没有血管收缩作用。 了解更多 -
Mozavaptan
Catalog No. A16622 nonpeptide vasopressin V2 receptor antagonistMozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM. 了解更多 -
Lixivaptan
Catalog No. A21279 vasopressin receptor V2 antagonistLixivaptan (VPA-985, WAY-VPA 985) is an orally active and selective vasopressin receptor V2 antagonist, with IC50 values of 1.2 and 2.3 nM for human and rat V2, respectively. 了解更多 -
Vasopressin antagonist 1867
Catalog No. A16188 V1b receptor 拮抗剂Vasopressin antagonist 1867,可口服和选择性V1b受体拮抗剂(hV1b抑制作用的IC50值为3 nM,相对于hV1a,hV2和hOT表现出> 1000倍的选择性)。 了解更多 -
Sigma-1 receptor antagonist 2
Catalog No. A18504 sigma 1 receptor antagonistSigma-1 receptor antagonist 2 is a potent and selective sigma 1 receptor (??1 R) antagonist with Kis of 3.88 and 1288 nM for ??1 and ??2 receptor, respectively. 了解更多 -
Sigma-1 receptor antagonist 3
Catalog No. A18501 Sigma-1 receptor antagonistSigma-1 receptor antagonist 3 (compound135) is a potent and selective Sigma-1 (??1) receptor antagonist with a Ki of 1.14 nM. 了解更多 -
S1RA (E-52862)
Catalog No. A12504 sigma-1 receptor 拮抗剂S1RA是一种选择性sigma-1受体拮抗剂,据报道其结合亲和力为Ki = 17.0±7.0 nM,对sigma-2受体具有选择性,并且对其他170种受体,酶,转运蛋白和离子通道具有选择性。 了解更多 -
BD-1047 2HBr
Catalog No. A13196 -
L-371,257
Catalog No. A21219 oxytocin receptor antagonistL-371,257 is an orally bioavailable, non-blood-brain barrier penetrant, selective and competitive antagonist of oxytocin receptor (pA2=8.4) with high affinity at both the oxytocin receptor (Ki=19 nM) and vasopressin V1a receptor (Ki=3.7 nM). 了解更多 -
GSK221149A (Retosiban)
Catalog No. A13106 Oxytocin Receptor 拮抗剂GSK221149A (Retosiban)是一种口服药物,可作为选择性纳摩尔(Ki = 0.65 nM)催产素受体拮抗剂,其选择性是相关血管加压素受体的> 1400倍。 了解更多 -
PF-3274167
Catalog No. A13754 -
KU14R
Catalog No. A13987 -
Proglumide
Catalog No. A18171 CCK antagonistProglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. IProglumide is a known cholecystokinin (CCK) antagonist. 了解更多 -
Dexloxiglumide
Catalog No. A18541 CCKA receptor antagonistDexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). 了解更多 -
Loxiglumide (CR1505)
Catalog No. A11769 -
Proglumide sodium salt
Catalog No. A13713 CCK 拮抗剂Proglumide sodium salt是一种非选择性胆囊收缩素(CCK)拮抗剂。它抑制CCK刺激的淀粉酶分泌,并防止CCK诱导的小鼠胰腺腺泡中的2-脱氧葡萄糖摄取。 了解更多 -
Z-360 calcium salt (Nastorazepide calcium salt)
Catalog No. A13671 CCK-2 receptor 拮抗剂Z-360 calcium salt (Nastorazepide calcium salt)是一种选择性口服可口服的1,5-苯并二氮杂卓衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在的抗肿瘤活性。 了解更多 -
Nastorazepide (Z-360)
Catalog No. A15984 CCK-2 receptor 拮抗剂Nastorazepide (Z-360) 是一种选择性的,口服的1,5-苯二氮杂卓衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在的抗肿瘤活性。 了解更多 -
NPS-2143 hydrochloride
Catalog No. A11505 CaSR antagonistNPS-2143 hydrochloride (SB-262470A hydrochloride), an orally active calcilytic agent, is a selective and potent calcium ion-sensing receptor (CaSR) antagonist. 了解更多 -
NPS-2143 (SB-262470)
Catalog No. A11140 CaSR 拮抗剂NPS-2143 (SB-262470)是一种选择性的Ca2+感应受体拮抗剂,显示可阻止HEK293细胞中表达的人Ca2+受体引起的细胞质Ca2+浓度增加,IC50为43 nM。 了解更多 -
Verucerfont
Catalog No. A16950 CRF-1 拮抗剂Verucerfont,也称为GSK561679和NBI77860,是CRF-1拮抗剂。Verucerfont阻止CRH-1受体,因此减少了慢性应激后ACTH的释放。 了解更多 -
Emicerfont
Catalog No. A14047 -
Pexacerfont
Catalog No. A14105 CRF1 receptor antagonistPexacerfont is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1??0.6 nM for human CRF1 receptor. 了解更多